\u718a\u535a\u58eb\u4e8e2017\u5e749\u6708\u81f32022\u5e746\u6708\u5728\u590d\u65e6\u5927\u5b66\u5316\u5b66\u751f\u7269\u5b66\u4e13\u4e1a\u653b\u8bfb\u535a\u58eb\u5b66\u4f4d\uff1b2022\u5e747\u6708\u8d77\u5728\u7fd4\u5b89\u521b\u65b0\u5b9e\u9a8c\u5ba4\uff08\u590f\u5b81\u90b5\u9662\u58eb\u56e2\u961f\uff09\u751f\u7269\u5206\u6790\u6d4b\u8bd5\u4e2d\u5fc3\u62c5\u4efb\u8d28\u8c31\u5e73\u53f0\u8d1f\u8d23\u4eba\u3002\u718a\u535a\u58eb\u81ea\u4e3b\u201c\u4ece0\u52301\u201d\u642d\u5efa\u8d28\u8c31\u5e73\u53f0\uff0c\u957f\u671f\u4ece\u4e8b\u751f\u7269\u8d28\u8c31\u86cb\u767d\u8d28\u7ec4\u5b66\u4e0e\u6297\u4f53\u4ece\u5934\u6d4b\u5e8f\u7814\u7a76\u3002\u56f4\u7ed5\u5355\u514b\u9686\u6297\u4f53\u8f7b\u91cd\u94feCDR\u7cbe\u51c6\u89e3\u6790\uff0c\u521b\u65b0\u6784\u5efa\u201c\u591a\u9176\u6e10\u8fdb\u5236\u5907\u2014\u5e8f\u5217\u7ec4\u88c5\u2014\u529f\u80fd\u9a8c\u8bc1\u201d\u7684\u95ed\u73af\u4f53\u7cfb\uff0c\u5e76\u5f00\u53d1\u5f00\u6e90\u8f6f\u4ef6XA-Novo\uff0c\u663e\u8457\u63d0\u5347\u590d\u6742\u6837\u672c\u4e2d\u86cb\u767d\u5e8f\u5217\u89e3\u6790\u7684\u51c6\u786e\u6027\u4e0e\u5de5\u7a0b\u53ef\u7528\u6027\u3002\u540c\u65f6\uff0c\u9762\u5411\u4e34\u5e8a\u8f6c\u5316\u9700\u6c42\uff0c\u6784\u5efa\u878d\u5408\u8d85\u9ad8\u5206\u8fa8\u8d28\u8c31\u3001\u591a\u7ec4\u5b66\u6574\u5408\u4e0e\u673a\u5668\u5b66\u4e60\u5206\u6790\u4f53\u7cfb\uff0c\u5b9e\u73b0HBV\u76f8\u5173\u809d\u75c5\u53ca\u52a8\u8109\u7ca5\u6837\u786c\u5316\u6027\u5352\u4e2d\u7b49\u590d\u6742\u75be\u75c5\u7684\u5206\u5b50\u7279\u5f81\u89e3\u6790\u4e0e\u9ad8\u7cbe\u5ea6\u6807\u5fd7\u7269\u7b5b\u9009\u3002\u8fd1\u4e94\u5e74\u53d1\u8868SCI\u8bba\u65879\u7bc7\uff0c\u83b7\u6388\u6743\u53d1\u660e\u4e13\u52293\u9879\uff0c\u4e3b\u6301\u591a\u9879\u56fd\u5bb6\u53ca\u7701\u5e02\u79d1\u7814\u9879\u76ee\uff0c\u5165\u9009\u798f\u5efa\u7701\u3001\u53a6\u95e8\u5e02\u9ad8\u5c42\u6b21C\u7c7b\u4eba\u624d\u3002<\/p>\n
<\/p>\n
\u4ee3\u8868\u4f5c\uff1a
\n1. Xiong Y#, Jiang W#, Xiao J#, Bu Q, Wang J, Jiang Z, Luo L, Chen X, Qiu Y, Wu Y, Liu F, Yu R, Xia N, Yuan Q. XA-Novo: high-throughput mass spectrometry-based de novo sequencing technology for monoclonal antibodies and antibody mixtures. Nature Communications, 2026. https:\/\/doi.org\/10.1038\/s41467-026-70496-y.
\n2. Xiao J#, Liu H#, Yao J#, Yang S, Shen F, Bu K, Wang Z, Liu F, Xia N, Yuan Q, Shu H, Xiong Y, Liu X. The Characterization of Serum Proteomics and Metabolomics across the Cancer Trajectory in Chronic Hepatitis B-Related Liver Diseases. View, 2024, 5(20240031).
\n3. Xiong Y#, Zheng Y#, Yan Y#, Yao J, Liu H, Shen F, Kong S, Yang S, Yan G, Zhao H, Zhou X, Hu J, Zhou B, Jin T, Leng B, Yang P&, Liu X. Circulating proteomic panels for risk stratification of intracranial aneurysms and its rupture. EMBO Molecular Medicine, 2022, 14(2): e14713.
\n4. Yang S#, Xiong Y#, Du Y#, Wang Y#, Zhang L, Shen F, Liu Y, Liu X, Yang P&. Ultra-sensitive trace sample proteomics unraveled the protein remodeling during mesenchymal-amoeboid transition. Analytical Chemistry, 2022, 94(2): 768-776.
\n5. Xiong Y, Yao J, Zheng Y, Shen F, Zhao H, Leng B, Yang P&, Liu X*. Comprehensive Mass Spectrometry for Development of Proteomic Biomarkers of Intracranial Aneurysms. Talanta, 2022, 240: 123159.<\/p>","protected":false},"featured_media":1468,"template":"","member_cat":[],"class_list":["post-1467","member","type-member","status-publish","has-post-thumbnail","hentry"],"acf":[],"_links":{"self":[{"href":"http:\/\/cnhupo.org.cn\/zh\/wp-json\/wp\/v2\/member\/1467","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/cnhupo.org.cn\/zh\/wp-json\/wp\/v2\/member"}],"about":[{"href":"http:\/\/cnhupo.org.cn\/zh\/wp-json\/wp\/v2\/types\/member"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/cnhupo.org.cn\/zh\/wp-json\/wp\/v2\/media\/1468"}],"wp:attachment":[{"href":"http:\/\/cnhupo.org.cn\/zh\/wp-json\/wp\/v2\/media?parent=1467"}],"wp:term":[{"taxonomy":"member_cat","embeddable":true,"href":"http:\/\/cnhupo.org.cn\/zh\/wp-json\/wp\/v2\/member_cat?post=1467"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}